Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sanofi SA (NASDAQ:GCVRZ)

0.45
Delayed Data
As of 3:58pm ET
 +0.05 / +12.50%
Today’s Change
0.08
Today|||52-Week Range
0.50
+18.42%
Year-to-Date
Key FDA Events to Watch Out for in Q1
9:06am / Zacks.com - Paid Partner Content
2 Top Stocks in Biotech
Jan 09 / MotleyFool.com - Paid Partner Content
David Herro's Oakmark International Fund Fourth Quarter Letter
Jan 11 / GuruFocus News - Paid Partner Content
Why Biotech Titans Are Clashing Over Cholesterol
Jan 08 / MotleyFool.com - Paid Partner Content
Sanofi, ImmuNext Ink Deal, Focus on Autoimmune Diseases
Jan 11 / Zacks.com - Paid Partner Content
Better Buy: Regeneron Pharmaceuticals, Inc. vs. Pfizer
Jan 07 / MotleyFool.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Clovis Oncology, Pfizer, Roche's, Sanofi and Regen...
Jan 10 / Zacks.com - Paid Partner Content
Amgen's Repatha Wins Over Sanofi & Regeneron's Praluent
Jan 06 / Zacks.com - Paid Partner Content
Amgen Inks Multiple Deals, Offers Update on Repatha Lawsuit
Jan 10 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: PCSK9 Inhibitor Praluent in News, Allergan's Preliminary 2017 V...
Jan 06 / Zacks.com - Paid Partner Content
Biotech Resolutions: More Innovation, Better Execution, and Fewer Price Hikes
Jan 10 / MotleyFool.com - Paid Partner Content
Obama's final jobs report; Trump hits Toyota; Indian GDP forecast
Jan 06 / CNNMoney.com
The FDA Approved Fewer Drugs in 2016: Here's Why
Jan 09 / Zacks.com - Paid Partner Content
How Risky Is Inovio Pharmaceuticals, Inc.?
Jan 05 / MotleyFool.com - Paid Partner Content
Impax (IPXL) Applies for Generic Aubagio; Sanofi Files Lawsuit
Jan 09 / Zacks.com - Paid Partner Content
Eli Lilly Acquires Boehringer Ingelheim's Pet Vaccines Unit
Jan 04 / Zacks.com - Paid Partner Content